Ariola, Fidel .
HRN: 04-09-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/06/2025
10/12/2025
IV
4.5
Q8
Dm Foot Wagner 5
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes